Transgenic Animal Models
Transgenic Animal Models - Related Videos
26:43
Computer-Generated Animal Model Stimuli
0 Views •
Cited by 8 •
2007
Computer-generated stimuli using the Jacky dragon as a model.
13:59
Assaying β-amyloid Toxicity using a Transgenic C. elegans Model
0 Views •
Cited by 76 •
2010
The intensely studied nematode worm Caenorhabditis elegans can be transgenically engineered to express the human β-amyloid peptide (Aβ). Induced expression of Aβ in C. elegans muscle leads to a rapid, reproducible paralysis phenotype that can be used to monitor treatments that modulate Aβ toxicity.
10:02
Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
0 Views •
Cited by 199 •
2017
Described here is a staged, behavioral screening approach that can be used to screen for compounds that exhibit in vivo efficacy on cognitive and functional motor behaviors in transgenic mouse models of β-amyloidosis and tauopathy. These methods are optimized to screen compounds for activity in short-term and working memory tasks.
09:45
An Isolated Working Heart System for Large Animal Models
0 Views •
Cited by 22 •
2014
Most studies involving the Langendorff apparatus use small animal models due to the increased complexity of systems for larger mammals. We describe a Langendorff system for large animal models that allows for use across a range of species, including humans, and relatively easy data acquisition.
07:02
Animal Model of Implant-Associated Infections in Mice
0 Views •
2025
The present protocol describes a mouse model employing subcutaneous dorsal implantation to investigate implant-associated infections, enabling comprehensive investigation of pathophysiological mechanisms and supporting the development of diagnostic criteria with targeted therapeutic strategies.
FAQs
Tissue-specific promoters restrict where an introduced gene becomes active, allowing researchers to examine its effects in selected neural cells or tissues rather than throughout the animal. This control helps connect gene activity with neuronal development, synaptic signaling, or behavior. It also reduces ambiguity when widespread expression would make it difficult to identify the relevant biological site.
Inducible systems provide control over when a gene is active, adding a time dimension to genetic experiments. Researchers can therefore examine gene effects during particular stages or conditions instead of observing only a permanently altered state. This is especially relevant when timing may influence neuronal development, synaptic signaling, disease pathways, or behavioral outcomes.
Gene disruption examines consequences of interfering with a gene, whereas other designs focus on expressing an introduced gene or controlling its activity with promoters or inducible systems. These approaches address different questions: disruption can reveal what changes when gene function is impaired, while regulated expression can test where or when gene activity produces a neural effect.
A useful model depends on how closely the chosen genetic change connects to the biological question. Researchers must consider the gene’s relationship to neuronal development, synaptic signaling, behavior, or neurological disease mechanisms, along with where and when its activity is controlled. These design choices determine which effects can be interpreted and which mechanisms the model can test.
A typical strategy begins by introducing DNA into a fertilized embryo or applying targeted genetic engineering. The resulting animals are then studied according to the selected expression or disruption design, including control through tissue-specific promoters or inducible systems when appropriate. This workflow links the engineered genetic change to measurable effects in living neural systems.
In neuroscience, these models help connect particular genes with neuronal development, synaptic signaling, behavior, and neurological disease mechanisms. They can also support investigation of disease pathways and evaluation of potential treatments. Because the genetic change operates in a living system, researchers can examine relationships among molecular activity, neural processes, and observable outcomes.
By altering or regulating genes associated with neural function, researchers can investigate how specific genetic changes relate to disease mechanisms. The models may help evaluate pathways involved in neurological disorders and provide a setting for assessing potential treatments. Findings still require careful interpretation because differences between animal and human biology can limit direct translation.